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Screening asymptomatic individuals remains the subject of
intense debate in medicine. In the beginning of 2014 the use of
screening for breast cancer in women was seriously
questioned based on studies from Canada (Toronto) and the
Netherlands (Leiden). It was shown that, particularly in wom-
en over 70 years, screening for breast cancer might even bring
more harm than benefit in terms of over diagnosis and thus
overtreatment. With respect to carotid artery disease, in Sep-
tember of this year the United States Preventive Services Task
Force (USPSTF) published a recommendation to oppose the
screening of the general adult population to detect asymptom-
atic carotid artery stenosis [1]. The Task Force found that
ultrasound may produce false-positives resulting in angiogra-
phy or even surgery, with the accompanying high risk of
stroke, heart attack, or death. This recommendation may be
important because it may influence insurance coverage.
How about screening individuals with asymptomatic cor-
onary artery disease? In a review article from the Netherlands
(Rotterdam) a systematic review of guidelines on imaging of
asymptomatic coronary artery disease showed the light in
2011 [2]. It turned out that guideline on risk assessment by
imaging of asymptomatic coronary artery disease contained
conflicting recommendations. Out of the 14 guidelines that
met the inclusion criteria, eight guidelines recommended
against or found insufficient evidence for testing individuals
with asymptomatic coronary artery disease. The authors sug-
gested therefore that more research, including randomized
controlled trials, is needed to evaluate the impact of imaging
on clinical outcomes and costs.
Over the past years cardiac computed tomography (CT) has
emerged as a screening tool - in addition to the proven use of
major risk factors - to detect coronary artery disease in an early
stage of its process [3–7]. Both calcium scoring and coronary
CT angiography have been shown useful to identify coronary
artery lesions. However, how does one manage the issue of
using coronary CT as a screening test in asymptomatic indi-
viduals? According to the 2013 ESC Guidelines on Stable
Angina Pectoris [8], both coronary calcium detection by CT
and coronary CT angiography receive a Class III indication,
meaning that there is ‘evidence and/or general agreement that
the procedure is not useful/effective and in some cases may be
harmful’. The inherent guideline recommendations were two-
fold: 1) coronary calcium detection by CT is not recommend-
ed to identify individuals with coronary artery disease, and 2)
coronary CT angiography is not recommended as a screening
test in asymptomatic individuals without clinical suspicion of
coronary artery disease.
Apart from the lack of usefulness of applying CT in asymp-
tomatic individuals one should always be aware of the risk of
radiation exposure using ionising imaging modalities to detect
patients with coronary artery disease. To that purpose, the
American Heart Association (AHA) very recently issued a
scientific statement on cardiac imaging, published online on
29 September 2014 in the journal Circulation [9]. The AHA
scientific statement recommended that exposure to radiation
should be part of the discussion on cardiac imaging for both
referring and performing physicians. Physicians should be
required to know which cardiac imaging tests use ionising
radiation, understand the basics of exposure, and know the
typical dose estimates for the most commonly used cardiac
imaging procedures. In addition, they should counsel patients
on the risks as well as on potential benefits so that patients can
give truly informed consent. Consequently, before referring a
patient for a cardiac imaging test, the AHA recommends that
physicians address important questions such as 1) how will
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the test help diagnose or treat the cardiac problem, 2) are there
alternative modalities not using radiation, 3) what are the
levels of radiation exposure, 4) how will it affect the risk of
cancer later in life, and 5) how does that compare with the risk
from other common activities. These questions remain perti-
nent despite successful technological attempts to reduce radi-
ation exposure, which holds in particular for cardiac CT.
To conclude, although screening for coronary artery dis-
ease -especially using advanced ionising cardiac imaging
techniques [10] - may be helpful in patients with a intermedi-
ate to high probability of disease, it may be redundant in
patients with a low prevalence of disease and even harmful
in asymptomatic individuals.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Jonas DE, Feltner C, Amick HR, et al. Screening for asymptomatic
carotid artery stenosis: a systematic review and meta-analysis for the
U.S. Preventive services task force. Ann Intern Med. 2014;161:336–
46.
2. Ferket BS, Genders TS, Colkesen EB, et al. Systematic review of
guidelines on imaging of asymptomatic coronary artery disease. J
Am Coll Cardiol. 2011;57:1591–600. doi:10.1016/j.jacc.2010.10.
055.
3. Meijs MF, Cramer MJ, El Aidi H, Doevendans PA. CT
fractional flow reserve: the next level in non-invasive cardiac
imaging. Neth Heart J. 2012;20:410–8. doi:10.1007/s12471-
012-0306-6.
4. WinterMM, Romeih S, BoumaBJ, et al. Is cardiac CTa reproducible
alternative for cardiac MR in adult patients with a systemic right
ventricle? Neth Heart J. 2012;20:456–62. doi:10.1007/s12471-012-
0310-x.
5. Yiu KH, de Graaf FR, van Velzen JE, et al. Different value of
coronary calcium score to predict obstructive coronary artery
disease in patients with and without moderate chronic kidney
disease. Neth Heart J. 2013;21:347–53. doi:10.1007/s12471-
013-0409-8.
6. van der Wall EE. Crown years for non-invasive cardiovascular im-
aging (Part IV): 30 years of cardiac computed tomography. Neth
Heart J. 2013;21:315–8. doi:10.1007/s12471-013-0427-6.
7. Nijveldt R, Pflederer T, Achenbach S. Coronary CT angiography in
the elderly. Neth Heart J. 2014;22:124–5. doi:10.1007/s12471-013-
0445-4.
8. Montalescot G, Sechtem U, Achenbach S, et al. Task force members.
2013 ESC guidelines on the management of stable coronary artery
disease: the task force on the management of stable coronary artery
disease of the European society of cardiology. Eur Heart J. 2013;13:
2949–3003. doi:10.1093/eurheartj/eht296.
9. Fazel R, Gerber TC, Balter S, et al. Approaches to Enhancing
Radiation Safety in Cardiovascular Imaging: A Scientific Statement
From the American Heart Association. Circulation, published online
29 September 2014.
10. van der Wall EE. Cost analysis favours SPECT over PET and CTA
for evaluation of coronary artery disease: the SPARC study. Neth
Heart J. 2014;22:257–8. doi:10.1007/s12471-014-0558-4.
532 Neth Heart J (2014) 22:531–532
